211 related articles for article (PubMed ID: 25385107)
1. Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.
Upton LM; Brock PM; Churcher TS; Ghani AC; Gething PW; Delves MJ; Sala KA; Leroy D; Sinden RE; Blagborough AM
Antimicrob Agents Chemother; 2015 Jan; 59(1):490-7. PubMed ID: 25385107
[TBL] [Abstract][Full Text] [Related]
2. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
Gerardin J; Eckhoff P; Wenger EA
BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.
Krudsood S; Tangpukdee N; Muangnoicharoen S; Thanachartwet V; Luplertlop N; Srivilairit S; Wilairatana P; Kano S; Ringwald P; Looareesuwan S
Korean J Parasitol; 2007 Jun; 45(2):111-4. PubMed ID: 17570973
[TBL] [Abstract][Full Text] [Related]
4. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa.
Barnes KI; Durrheim DN; Little F; Jackson A; Mehta U; Allen E; Dlamini SS; Tsoka J; Bredenkamp B; Mthembu DJ; White NJ; Sharp BL
PLoS Med; 2005 Nov; 2(11):e330. PubMed ID: 16187798
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector.
van Pelt-Koops JC; Pett HE; Graumans W; van der Vegte-Bolmer M; van Gemert GJ; Rottmann M; Yeung BK; Diagana TT; Sauerwein RW
Antimicrob Agents Chemother; 2012 Jul; 56(7):3544-8. PubMed ID: 22508309
[TBL] [Abstract][Full Text] [Related]
7. Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine.
Rutledge GG; Marr I; Huang GKL; Auburn S; Marfurt J; Sanders M; White NJ; Berriman M; Newbold CI; Anstey NM; Otto TD; Price RN
Emerg Infect Dis; 2017 Aug; 23(8):1300-1307. PubMed ID: 28430103
[TBL] [Abstract][Full Text] [Related]
8. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
[TBL] [Abstract][Full Text] [Related]
9. Blocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysis.
Abay SM
Parasit Vectors; 2013 Sep; 6(1):278. PubMed ID: 24499628
[TBL] [Abstract][Full Text] [Related]
10. Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data.
WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group
BMC Med; 2015 Sep; 13():227. PubMed ID: 26381375
[TBL] [Abstract][Full Text] [Related]
11. Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance.
Nnamani PO; Ugwu AA; Ibezim EC; Kenechukwu FC; Akpa PA; Ogbonna JN; Obitte NC; Odo AN; Windbergs M; Lehr CM; Attama AA
Int J Nanomedicine; 2016; 11():6365-6378. PubMed ID: 27932882
[TBL] [Abstract][Full Text] [Related]
12. Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial.
Staedke SG; Mwebaza N; Kamya MR; Clark TD; Dorsey G; Rosenthal PJ; Whitty CJ
Lancet; 2009 May; 373(9675):1623-31. PubMed ID: 19362361
[TBL] [Abstract][Full Text] [Related]
13. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
Bassat Q
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1325. PubMed ID: 22216359
[TBL] [Abstract][Full Text] [Related]
14. In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.
Hwang J; Alemayehu BH; Reithinger R; Tekleyohannes SG; Takele Teshi ; Birhanu SG; Demeke L; Hoos D; Melaku Z; Kassa M; Jima D; Malone JL; Nettey H; Green M; Poe A; Akinyi S; Udhayakumar V; Kachur SP; Filler S
PLoS One; 2013; 8(5):e63433. PubMed ID: 23717423
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, Randomized, Multicenter Trial in India and Africa.
Toure OA; Mwapasa V; Sagara I; Gaye O; Thompson R; Maheshwar AV; Mishra P; Behra N; Tshefu AK; Das RR; Anvikar AR; Sharma P; Roy A; Sharma SK; Nasa A; Jalali RK; Valecha N;
Clin Infect Dis; 2017 Oct; 65(10):1711-1720. PubMed ID: 29020247
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.
Tripura R; von Seidlein L; Sovannaroth S; Peto TJ; Callery JJ; Sokha M; Ean M; Heng C; Conradis-Jansen F; Madmanee W; Peerawaranun P; Waithira N; Khonputsa P; Jongdeepaisal M; Pongsoipetch K; Chotthanawathit P; Soviet U; Pell C; Duanguppama J; Rekol H; Tarning J; Imwong M; Mukaka M; White NJ; Dondorp AM; Maude RJ
Lancet Infect Dis; 2023 Jan; 23(1):81-90. PubMed ID: 36174595
[TBL] [Abstract][Full Text] [Related]
17. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
[TBL] [Abstract][Full Text] [Related]
18. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.
Eziefula AC; Bousema T; Yeung S; Kamya M; Owaraganise A; Gabagaya G; Bradley J; Grignard L; Lanke KH; Wanzira H; Mpimbaza A; Nsobya S; White NJ; Webb EL; Staedke SG; Drakeley C
Lancet Infect Dis; 2014 Feb; 14(2):130-9. PubMed ID: 24239324
[TBL] [Abstract][Full Text] [Related]
19. Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.
Medzihradsky OF; Kleinschmidt I; Mumbengegwi D; Roberts KW; McCreesh P; Dufour MK; Uusiku P; Katokele S; Bennett A; Smith J; Sturrock H; Prach LM; Ntuku H; Tambo M; Didier B; Greenhouse B; Gani Z; Aerts A; Gosling R; Hsiang MS
BMJ Open; 2018 Jan; 8(1):e019294. PubMed ID: 29374672
[TBL] [Abstract][Full Text] [Related]
20. Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.
Nyunt MM; Nguyen VK; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Mwima MW; Achan J; Aweeka F; Parikh S; Mwebaza N
Antimicrob Agents Chemother; 2015 Dec; 60(3):1274-82. PubMed ID: 26666942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
